T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Rivian
RIVN
|
+$16.1B |
| 2 |
Apple
AAPL
|
+$6.15B |
| 3 |
NVIDIA
NVDA
|
+$5.7B |
| 4 |
Tesla
TSLA
|
+$4.7B |
| 5 |
Microsoft
MSFT
|
+$2.23B |
Top Sells
| 1 |
Visa
V
|
+$4.3B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.34B |
| 3 |
Morgan Stanley
MS
|
+$2.78B |
| 4 |
Global Payments
GPN
|
+$2.39B |
| 5 |
PayPal
PYPL
|
+$1.74B |
Sector Composition
| 1 | Technology | 27.48% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.75% |
| 4 | Communication Services | 12.37% |
| 5 | Financials | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Acacia Research
ACTG
$326M
| $172K | ﹤0.01% |
33,595
-800
| -2% | -$4.1K |
|
2777
Clover Health Investments
CLOV
$1.4B
| $172K | ﹤0.01% |
46,317
+21,745
| +88% | +$80.8K |
|
2778
Greenlight Captial
GLRE
$434M
| $172K | ﹤0.01% |
21,877
-970
| -4% | -$7.63K |
|
|
SEI
2779
Solaris Energy Infrastructure, Inc.
SEI
$1.16B
| $172K | ﹤0.01% |
26,307
-10,500
| -29% | -$68.7K |
|
|
MYOV
2780
DELISTED
Myovant Sciences Ltd.
MYOV
| $170K | ﹤0.01% |
+10,900
| New | +$170K |
|
2781
Westwater Resources
WWR
$61.8M
| $169K | ﹤0.01% |
78,400
+23,200
| +42% | +$50K |
|
|
TCRR
2782
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $169K | ﹤0.01% |
+36,281
| New | +$169K |
|
2783
Gevo
GEVO
$397M
| $168K | ﹤0.01% |
39,175
-50,535
| -56% | -$217K |
|
2784
Qualigen Therapeutics
QLGN
$2.93M
| $166K | ﹤0.01% |
309
+94
| +44% | +$50.5K |
|
2785
Ecovyst
ECVT
$1.05B
| $165K | ﹤0.01% |
16,138
-767
| -5% | -$7.84K |
|
2786
Purple Innovation
PRPL
$118M
| $165K | ﹤0.01% |
12,449
-18,146
| -59% | -$241K |
|
2787
VistaGen Therapeutics
VTGN
$107M
| $165K | ﹤0.01% |
2,812
+950
| +51% | +$55.7K |
|
2788
Crescent Energy
CRGY
$2.12B
| $164K | ﹤0.01% |
+12,924
| New | +$164K |
|
2789
LifeVantage
LFVN
$144M
| $164K | ﹤0.01% |
25,900
| – | – |
|
2790
Cullinan Oncology
CGEM
$404M
| $164K | ﹤0.01% |
+10,627
| New | +$164K |
|
|
ATRS
2791
DELISTED
Antares Pharma, Inc.
ATRS
| $162K | ﹤0.01% |
45,257
-3,200
| -7% | -$11.5K |
|
|
CHMI
2792
Cherry Hill Mortgage Investment Corp
CHMI
$106M
| $157K | ﹤0.01% |
19,030
| – | – |
|
|
BHR
2793
Braemar Hotels & Resorts
BHR
$203M
| $154K | ﹤0.01% |
30,130
-703
| -2% | -$3.59K |
|
2794
Vitamin Cottage Natural Grocers
NGVC
$878M
| $154K | ﹤0.01% |
10,809
-200
| -2% | -$2.85K |
|
|
NKLA
2795
DELISTED
Nikola Corporation Common Stock
NKLA
| $154K | ﹤0.01% |
519
-110
| -17% | -$32.6K |
|
2796
Rafael Holdings
RFL
$47M
| $153K | ﹤0.01% |
+30,350
| New | +$153K |
|
2797
CleanSpark
CLSK
$2.58B
| $152K | ﹤0.01% |
+15,974
| New | +$152K |
|
2798
DURECT Corp
DRRX
$60.9M
| $150K | ﹤0.01% |
15,192
-3,976
| -21% | -$39.3K |
|
|
LHDX
2799
DELISTED
Lucira Health, Inc. Common Stock
LHDX
| $150K | ﹤0.01% |
17,400
+7,200
| +71% | +$62.1K |
|
|
SHCR
2800
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $149K | ﹤0.01% |
+33,200
| New | +$149K |
|